Center-Authored Papers

Filters: Author is Minasian, Lori M  [Clear All Filters]
2009
Lippman SM, Klein EA, Goodman PJ, Lucia SM, Thompson IM, Ford LG, Parnes HL, Minasian LM, Gaziano MJ, Hartline JA et al..  2009.  Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).. JAMA : the journal of the American Medical Association. 301(1):39-51. Abstract
2010
Cook ED, Arnold KB, Hermos JA, McCaskill-Stevens W, Moody-Thomas S, Probstfield JL, Hamilton SJ, Campbell RD, Anderson KB, Minasian LM.  2010.  Impact of supplemental site grants to increase African American accrual for the Selenium and Vitamin E Cancer Prevention Trial.. Clinical trials (London, England). 7(1):90-9. Abstract
Freedman AN, Sansbury LB, Figg WD, Potosky AL, Weiss Smith SR, Khoury MJ, Nelson SA, Weinshilboum RM, Ratain MJ, McLeod HL et al..  2010.  Cancer pharmacogenomics and pharmacoepidemiology: setting a research agenda to accelerate translation.. Journal of the National Cancer Institute. 102(22):1698-705. Abstract
2011
Marshall JR, Tangen CM, Sakr WA, Wood DP, Berry DL, Klein EA, Lippman SM, Parnes HL, Alberts DS, Jarrard DF et al..  2011.  Phase III Trial of Selenium to Prevent Prostate Cancer in Men with High-grade Prostatic Intraepithelial Neoplasia: SWOG S9917.. Cancer prevention research (Philadelphia, Pa.). 4(11):1761-9. Abstract
Klein EA, Thompson IM, Tangen CM, Crowley J, Lucia SM, Goodman PJ, Minasian LM, Ford LG, Parnes HL, Gaziano MJ et al..  2011.  Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).. JAMA : the journal of the American Medical Association. 306(14):1549-56. Abstract
2012
Goodman PJ, Hartline JA, Tangen CM, Crowley JJ, Minasian LM, Klein EA, Cook ED, Darke AK, Arnold KB, Anderson K et al..  2012.  Moving a randomized clinical trial into an observational cohort.. Clinical trials (London, England). Abstract
2013
Thompson IM, Goodman PJ, Tangen CM, Parnes HL, Minasian LM, Godley PA, Lucia SM, Ford LG.  2013.  Long-term survival of participants in the prostate cancer prevention trial.. The New England journal of medicine. 369(7):603-10. Abstract
Brasky TM, Darke AK, Song X, Tangen CM, Goodman PJ, Thompson IM, Meyskens FL, Goodman GE, Minasian LM, Parnes HL et al..  2013.  Plasma Phospholipid Fatty Acids and Prostate Cancer Risk in the SELECT Trial.. Journal of the National Cancer Institute. 105(15):1132-1141. Abstract
Hershman DL, Unger JM, Crew KD, Minasian LM, Awad D, Moinpour CM, Hansen L, Lew DL, Greenlee H, Fehrenbacher L et al..  2013.  Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for the prevention of taxane-induced neuropathy in women undergoing adjuvant breast cancer therapy.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 31(20):2627-33. Abstract
2014
Kristal AR, Till CA, Song X, Tangen CM, Goodman PJ, Neuhouser ML, Schenk JM, Thompson IM, Meyskens FL, Goodman GE et al..  2014.  Plasma Vitamin D and Prostate Cancer Risk; Results from the Selenium and Vitamin E Cancer Prevention Trial.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Abstract
Kristal AR, Darke AK, Morris SJ, Tangen CM, Goodman PJ, Thompson IM, Meyskens FL, Goodman GE, Minasian LM, Parnes HL et al..  2014.  Baseline Selenium Status and Effects of Selenium and Vitamin E Supplementation on Prostate Cancer Risk.. Journal of the National Cancer Institute. Abstract
Gritz ER, Arnold KB, Moinpour CM, Burton-Chase AM, Tangen CM, Probstfield JF, See WA, Lieber MM, Caggiano V, Moody-Thomas S et al..  2014.  Factors Associated with Adherence to an End-of-Study Biopsy: Lessons from the Prostate Cancer Prevention Trial (SWOG-Coordinated Intergroup Study S9217).. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Abstract
2015
Cassano PA, Guertin KA, Kristal AR, Ritchie KA, Bertoia ML, Arnold KB, Crowley JJ, Hartline JA, Goodman PJ, Tangen CM et al..  2015.  A randomized controlled trial of vitamin E and selenium on rate of decline in lung function.. Respiratory research. 16(1):35. Abstract
Hershman DL, Unger JM, Crew KD, Awad D, Dakhil SR, Gralow J, Greenlee H, Lew DL, Minasian LM, Till C et al..  2015.  Randomized Multicenter Placebo-Controlled Trial of Omega-3 Fatty Acids for the Control of Aromatase Inhibitor-Induced Musculoskeletal Pain: SWOG S0927.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. Abstract
Minasian LM, Tangen CM, Wickerham LD.  2015.  Ongoing Use of Data and Specimens From National Cancer Institute-Sponsored Cancer Prevention Clinical Trials in the Community Clinical Oncology Program.. Seminars in oncology. 42(5):748-63. Abstract
2016
Goodman PJ, Tangen CM, Darke AK, Arnold KB, Hartline JA, Yee M, Anderson K, Caban-Holt A, Christen WG, Cassano PA et al..  2016.  Opportunities and challenges in incorporating ancillary studies into a cancer prevention randomized clinical trial.. Trials. 17:400. Abstract
Unger JM, Till C, Thompson IM, Tangen CM, Goodman PJ, Wright JD, Barlow WE, Ramsey SD, Minasian LM, Hershman DL.  2016.  Long-term Consequences of Finasteride vs Placebo in the Prostate Cancer Prevention Trial.. Journal of the National Cancer Institute. 108(12) Abstract
Guertin KA, Grant RK, Arnold KB, Burwell L, Hartline JA, Goodman PJ, Minasian LM, Lippman SM, Klein E, Cassano PA.  2016.  Effect of long-term vitamin E and selenium supplementation on urine F2-isoprostanes, a biomarker of oxidative stress.. Free radical biology & medicine. 95:349-356. Abstract
Hershman DL, Till C, Wright JD, Awad D, Ramsey SD, Barlow WE, Minasian LM, Unger J.  2016.  Comorbidities and Risk of Chemotherapy-Induced Peripheral Neuropathy Among Participants 65 Years or Older in Southwest Oncology Group Clinical Trials.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. Abstract
2017
Lee SM, Zhang Y, Minasian LM, Unger JM, Hershman DL.  2017.  Using Delayed Toxicities to Re-evaluate Tolerability in Phase 2 Trials: A Case Example using Bortezomib.. Cancer investigation. :1-6. Abstract